title: MAGE antigens: therapeutic targets in hepatocellular carcinoma?
authors.forename: Pablo
authors.initials: P
authors.lastname: Sarobe
authors.forename: Esperanza
authors.initials: E
authors.lastname: Feijoó
authors.forename: Carlos
authors.initials: C
authors.lastname: Alfaro
authors.forename: Guillermo
authors.initials: G
authors.lastname: Mazzolini
authors.forename: Ignacio
authors.initials: I
authors.lastname: Melero
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000378:metabolism* / Q000628:therapy*; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000378:metabolism*
chemical_list: D000951:Antigens, Neoplasm; C072011:MAGEA1 protein, human; C072013:MAGEA3 protein, human; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins